Why Amarin's Latest News Caused Shares to Crash 13% Today - Motley Fool

Motley Fool

Why Amarin's Latest News Caused Shares to Crash 13% Today Motley Fool Amarin delivered welcome news to investors in September when it reported that a cardiovascular outcomes trial showed its only commercial drug, Vascepa, reduces the risk of heart attack, stroke, and cardiovascular-related deaths. A woman shrugs in front ... and more »

from news - Google News https://ift.tt/2E1jZL8
//